Sensitive Liquid Chromatographic Determination of Clarithromycin and 14-Hydroxy Clarithromycin in Human Plasma with Tandem Mass Spectrometry

REFERENCES

• Rodvold , K.A. Clinical Pharmacokinetics of clarithromycin . Clin. Pharmacokinetics. 1999 , 37 ( 5 ), 385 – 398 .
   PubMed Web of Science ®Google Scholar
• Piscitelli , S.C. ; Danziger , L.H. ; Rodvold , K.A. Clarithromycin and azithromycin: New macrolide antibiotics . Clin. Pharm. 1992 , 11 ( 2 ), 137 – 152 .
   PubMedGoogle Scholar
• Hardy , D.J. ; Guay , D.R.P. ; Jones , R.N. Clarithromycin, a unique macrolide: A pharmacokinetic, macrobiological, and clinical overview . Diagn. Microbiol. Infect. Dis. 1992 , 15 ( 1 ), 39 – 53 .
   PubMed Web of Science ®Google Scholar
• Fernandez , P.B. ; Ramer , R. ; Rode , R.A. ; Freiberg , L.A. Bioassay for A-56268 (TE-031) and identification of its major metabolite 14-hydroxy-6-O-methyl erythromycin . Eur. J. Clin. Microbiol. Infect. Dis. 1988 , 7 ( 1 ), 73 – 76 .
   PubMed Web of Science ®Google Scholar
• Davey , P.G. The pharmacokinetics of clarithromycin and its 14-OH metabolite . J. Hosp. Infect. 1991 , 19 ( 1 ), 29 – 37 .
   PubMedGoogle Scholar
• Sturgill , M.G. ; Rapp , R.P. Clarithromycin: Review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles . Ann. Pharmacother. 1992 , 26 ( 9 ), 1099 – 1108 .
   PubMed Web of Science ®Google Scholar
• Amsden , G.W. Erythromycin, clarithromycin, and azithromycin: Are the differences real? Clin . Ther. 1996 , 18 ( 1 ), 56 – 73 .
   PubMed Web of Science ®Google Scholar
• Franschini , F. ; Scaglione , F. ; Demartini , G. Clarithromycin clinical pharmacokinetics . Clin. Pharma. 1993 , 25 ( 3 ), 189 – 204 .
   Google Scholar
• Barradell , L.B. ; Plosker , G.L. ; McTavish , D. Clarithromycin: A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immunodeficiency syndrome . Drugs. 1993 , 46 ( 2 ), 289 – 312 .
   PubMed Web of Science ®Google Scholar
• Fernandes , P.B. ; Hardy , D.J. ; McDaniel , D. ; Hanson , C.W. ; Swanson , R.N. In vitro and in vivo activities of clarithromycin against Mycobacterium avium . Antimicrob. Agents Chemother. 1989 , 33 ( 9 ), 1531 – 1534 .
   PubMed Web of Science ®Google Scholar
• Dautzenberg , B. ; Truffot , C. ; Legris , S. ; Meyohas , M.C. ; Berlie , H.C. ; Mercat , A. ; Chevret , S. ; Grosset , J. Activity of clarithromycin against Mycobacterium avium infection in patients with acquired immune deficiency syndrome . Am. Rev. Respir. Dis. 1991 , 144 ( 3 ), 564 – 569 .
   PubMed Web of Science ®Google Scholar
• Chaisson , R.E. ; Benson , C.A. ; Dube , M.P. ; Heifets , L.B. ; Korvick , J.A. ; Elkin , S. ; Smith , T. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: A Randomized, Double-Blind, Dose-ranging Study in patients with AIDS . Ann. Intern. Med. 1994 , 121 ( 12 ), 905 – 911 .
   PubMed Web of Science ®Google Scholar
• Hardy , D.J. ; Swanson , R.N. ; Rode , R.A. ; Marsh , M. ; Shipkowitz , N.L. ; Clement , J.J. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob. Agents Chemother. 1990, 34 (7), 1407–1413.
   PubMed Web of Science ®Google Scholar
• Jorgensen , J.H. ; Maher , L.A. ; Howell , A.W. Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae . Antimicrob. Agents Chemother. 1991 , 35 ( 7 ), 1524 – 1526 .
   PubMed Web of Science ®Google Scholar
• Benninger , P. ; Cooper , A. ; Moisan , R. ; Patel , P. ; Elvin , A. ; Thiessen , J.J. A comparative clarithromycin bioavailability study: Determination of clarithromycin and 14-(R)-hydroxy clarithromycin under fasting and fed conditions . Int. J. Clin. Pharmacol. Ther. 2004 , 42 ( 6 ), 342 – 349 .
   PubMed Web of Science ®Google Scholar
• Lerner , F.E. ; Caliendo , G. ; Santagada , V. ; Santana , G.S.M. ; Moraes , M.E.A. ; De Nucci , G. Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers . Int. J. Clin. Pharmacol. Ther. 2000 , 38 ( 7 ), 345 – 354 .
   PubMed Web of Science ®Google Scholar
• Chu , S.Y. ; Sennello , L.T. ; Sonders , R.C. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine high-performance liquid chromatography with electrochemical detection . J. Chromatogr. 1991 , 571 ( 1–2 ), 199 – 208 .
   PubMedGoogle Scholar
• Hedenmo , M. ; Eriksson , B.M. Liquid chromatographic determination of the macrolide antibiotics roxithromycin and clarithromycin in plasma by automated solid-phase extraction and electrochemical detection . J. Chromatogr. 1995 , 692 ( 1–2 ), 161 – 166 .
   Google Scholar
• Kees , F. ; Spangler , S. ; Wellenhofer , M. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection . J. Chromatogr. 1998 , 812 ( 1–2 ), 287 – 293 .
   Google Scholar
• Sastre , T.J. ; Guchelaar , H.J. Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenyl- methyloxycarbonyl chloride and fluorescence detection . J. Chromatogr. B. Biomed. Sci. Appl. 1998 , 720 ( 1–2 ), 89 – 97 .
   PubMedGoogle Scholar
• Wenkui , L. ; Rettig , J. ; Jiang , X. ; Francisco , D.T. ; Naidong , W. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma . Biomed. Chromatogr. 2006 , 20 ( 11 ), 1242 – 1251 .
   PubMed Web of Science ®Google Scholar
• Jiang , Y. ; Wang , J. ; Li , H. ; Wang , Y. ; Gu , J. Determination of clarithromycin in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry . J. Pharma. Biomed. Ana. 2007 , 43 ( 4 ), 1460 – 1464 .
   PubMed Web of Science ®Google Scholar